SHINE Medical Technologies, Inc., 39342-39343 [2013-15678]

Download as PDF 39342 Federal Register / Vol. 78, No. 126 / Monday, July 1, 2013 / Notices Subcommittee reports to the Science Committee of the NAC. The Meeting will be held via Teleconference and WebEx for the purpose of soliciting, from the scientific community and other persons, scientific and technical information relevant to program planning. Friday, July 19, 2013, 9:00 a.m. to 12:00 noon, local time. ADDRESSES: This meeting will take place telephonically and by WebEx. Any interested person may call the USA toll free conference call number 800–857– 7040, pass code PSS, to participate in this meeting by telephone. The WebEx link is https://nasa.webex.com/, meeting number 994 987 970, and password PSS@Jul19. FOR FURTHER INFORMATION CONTACT: Ms. Marian Norris, Science Mission Directorate, NASA Headquarters, Washington, DC 20546, (202) 358–4452, fax (202) or mnorris@nasa.gov. SUPPLEMENTARY INFORMATION: The agenda for the meeting includes the following topics: —Status of Budget and Programmatic Impacts on the Planetary Science Division —Briefing from the Mars Exploration Program Regarding the Recommendations of the Mars 2020 Science Definition Team It is imperative that the meeting be held on this date to accommodate the scheduling priorities of the key participants. DATES: Susan M. Burch, Acting Advisory Committee Management Officer, National Aeronautics and Space Administration. [FR Doc. 2013–15677 Filed 6–28–13; 8:45 am] BILLING CODE 7510–13–P NUCLEAR REGULATORY COMMISSION [Docket No. 50–608; NRC–2013–0053] SHINE Medical Technologies, Inc. Nuclear Regulatory Commission. ACTION: Notice; acceptance for docketing. AGENCY: The NRC staff has determined that the partial application for a construction permit, submitted by SHINE Medical Technologies, Inc., is acceptable for docketing. ADDRESSES: Please refer to Docket ID NRC–2013–0053 when contacting the NRC about the availability of information regarding this document. You may access information related to mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 21:38 Jun 28, 2013 Jkt 229001 this document, which the NRC possesses and is publicly available, using any of the following methods: • Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC–2013–0053. Address questions about NRC dockets to Carol Gallagher; telephone: 301–492–3668; email: Carol.Gallagher@nrc.gov. For technical questions, contact the individual(s) listed in the FOR FURTHER INFORMATION CONTACT section of this document. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may access publicly available documents online in the NRC Library at http://www.nrc.gov/readingrm/adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The application is available in ADAMS under accession number ML130880226. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. FOR FURTHER INFORMATION CONTACT: Steven Lynch, Project Manager, Office of Nuclear Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC, 20555–0001; telephone: 301–415–1524; email: Steven.Lynch@nrc.gov. SUPPLEMENTARY INFORMATION: On March 26, 2013, SHINE Medical Technologies (SHINE) filed with the U.S. Nuclear Regulatory Commission (NRC), pursuant to Section 103 of the Atomic Energy Act and part 50 of Title 10 of the Code of Federal Regulations (10 CFR), a portion of an application for a construction permit for a medical radioisotope production facility in Janesville, Wisconsin (SMT–2013–012, NRC’s ADAMS Accession No. ML13088A192). A notice of receipt and availability of this application was previously published in the Federal Register (78 FR 29390) on May 20, 2013. An exemption from certain requirements of 10 CFR 2.101(a)(5) granted by the Commission on March 20, 2013 (ADAMS Accession No. ML13072B195), in response to a letter from SHINE dated February 18, 2013 (ADAMS Accession No. ML13051A007), allowed for SHINE to submit its construction permit application in two parts. Specifically, the exemption allowed SHINE to submit a portion of its application for a construction permit up PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 to six months prior to the remainder of the application regardless of whether or not an environmental impact statement or a supplement to an environmental impact statement is prepared during the review of its application. The first part of SHINE’s construction permit application consisted of the following information: • The description and safety assessment of the site required by 10 CFR 50.34(a)(1) • The environmental report required by 10 CFR 50.30(f) • The filing fee information required by 10 CFR 50.30(e) and 10 CFR 170.21 • The general information required by 10 CFR 50.33 • The agreement limiting access to classified information required by 10 CFR 50.37 The NRC staff has determined that SHINE has submitted the information listed above in accordance with 10 CFR 2.101(a)(5), and that the partial application is acceptable for docketing. The docket number established for SHINE is 50–608. The NRC staff will perform a detailed technical review of the partial construction permit application. Docketing of the partial construction permit application does not preclude the NRC from requesting additional information from the applicant as the review proceeds, nor does it predict whether the Commission will grant or deny the application. The NRC staff will also perform an acceptance review of the second and final part of the construction permit application when it is tendered. As stated in SHINE’s March 26, 2013, letter, the second and final part of SHINE’s application for a construction permit will contain the remainder of the preliminary safety analysis report required by 10 CFR 50.34(a) and will be submitted in accordance with the requirements of 10 CFR 2.101(a)(5). If, after completion of the acceptance review of the full construction permit application, the full construction permit application is found acceptable for docketing, the Commission will conduct a hearing in accordance with Subpart L, ‘‘Informal Hearing Procedures for NRC Adjudications,’’ of 10 CFR Part 2 and will receive a report on the construction permit application from the Advisory Committee on Reactor Safeguards consistent with 10 CFR 50.58, ‘‘Hearings and report of the Advisory Committee on Reactor Safeguards.’’ The Commission will announce in a future Federal Register notice, the opportunity to petition for leave to intervene in the hearing required for this application by 10 CFR 50.58, as well as the time and E:\FR\FM\01JYN1.SGM 01JYN1 Federal Register / Vol. 78, No. 126 / Monday, July 1, 2013 / Notices place of the hearing. If the Commission finds that the full construction permit application meets the applicable standards of the Atomic Energy Act and the Commission’s regulations, and that required notifications to other agencies and bodies have been made, the Commission will issue a construction permit, in the form and containing conditions and limitations that the Commission finds appropriate and necessary. In accordance with 10 CFR part 51, the Commission will also prepare an environmental impact statement for the proposed action. Pursuant to 10 CFR 51.26, and as part of the environmental scoping process, the NRC staff intends to hold a public scoping meeting. Detailed information regarding this meeting will be included in a future Federal Register notice. Dated at Rockville, Maryland, this 25th day of June, 2013. For the Nuclear Regulatory Commission. Alexander Adams, Jr., Chief, Research and Test Reactors Licensing Branch, Division of Policy and Rulemaking, Office of Nuclear Reactor Regulation. [FR Doc. 2013–15678 Filed 6–28–13; 8:45 am] BILLING CODE 7590–01–P [Docket No. 50–608; NRC–2013–0053] SHINE Medical Technologies, Inc. Nuclear Regulatory Commission. ACTION: Intent to prepare environmental impact statement and conduct scoping process; public meeting. AGENCY: This notice advises the public that the NRC intends to gather the information necessary to prepare an Environmental Impact Statement for construction and operation of the proposed SHINE radioisotope production facility. DATES: Submit comments by August 30, 2013. Comments received after this date will be considered if it is practical to do so, but the Commission is able to ensure consideration only for comments received before this date. ADDRESSES: You may submit comments by any of the following methods (unless this document describes a different method for submitting comments on a specific subject): • Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC–2013–0053. Address questions about NRC dockets to Carol Gallagher; telephone: 301–492–3668; mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: 21:38 Jun 28, 2013 FOR FURTHER INFORMATION CONTACT: Michelle Moser, Project Manager, Office of Nuclear Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC, 20555–0001; telephone: 301–415–6509; email: Michelle.Moser@nrc.gov. SUPPLEMENTARY INFORMATION: I. Accessing Information and Submitting Comments A. Accessing Information NUCLEAR REGULATORY COMMISSION VerDate Mar<15>2010 email: Carol.Gallagher@nrc.gov. For technical questions, contact the individual(s) listed in the FOR FURTHER INFORMATION CONTACT section of this document. • Mail comments to: Cindy Bladey, Chief, Rules, Announcements, and Directives Branch (RADB), Office of Administration, Mail Stop: TWB–05– B01M, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001. For additional direction on accessing information and submitting comments, see ‘‘Accessing Information and Submitting Comments’’ in the SUPPLEMENTARY INFORMATION section of this document. Jkt 229001 Please refer to Docket ID NRC–2013– 0053 when contacting the NRC about the availability of information regarding this document. You may access information related to this document, which the NRC possesses and is publicly available, by any of the following methods: • Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC–2013–0053. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may access publicly available documents online in the NRC Library at http://www.nrc.gov/readingrm/adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The ER is available in ADAMS under Accession Number ML130880226. In addition, the ER is available to the public near the site at the Hedberg Public Library, 316 South Main Street, Janesville, Wisconsin 53545. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. PO 00000 Frm 00093 Fmt 4703 Sfmt 4703 39343 B. Submitting Comments Please include Docket ID NRC–2013– 0053 in the subject line of your comment submission, in order to ensure that the NRC is able to make your comment submission available to the public in this docket. The NRC cautions you not to include identifying or contact information that you do not want to be publicly disclosed in your comment submission. The NRC will post all comment submissions at http:// www.regulations.gov as well as enter the comment submissions into ADAMS. The NRC does not routinely edit comment submissions to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the NRC, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that the NRC does not routinely edit comment submissions to remove such information before making the comment submissions available to the public or entering the comment submissions into ADAMS. II. Discussion SHINE Medical Technologies, Inc. (SHINE) has submitted a partial application for a construction permit to construct a radioisotope production facility. The proposed SHINE facility would be located approximately four miles south of Janesville, Wisconsin. The first part of the application for the construction permit, dated March 26, 2013, was submitted pursuant to part 50 of Title 10 of the Code of Federal Regulations (10 CFR) and included an environmental report (ER). A separate notice of receipt and availability of this portion of the application was published in the Federal Register on May 20, 2013 (78 FR 29390). A notice of acceptance for docketing of the first part of the construction permit application is also being published separately in the Federal Register. The purpose of this notice is to inform the public that the U.S. Nuclear Regulatory Commission (NRC) will be preparing an environmental impact statement (EIS) related to the review of the construction permit application and to provide the public an opportunity to participate in the environmental scoping process, as defined in 10 CFR 51.29. As outlined in 36 CFR 800.8, ‘‘Coordination with the National Environmental Policy Act,’’ the NRC plans to coordinate compliance with E:\FR\FM\01JYN1.SGM 01JYN1

Agencies

[Federal Register Volume 78, Number 126 (Monday, July 1, 2013)]
[Notices]
[Pages 39342-39343]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-15678]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 50-608; NRC-2013-0053]


SHINE Medical Technologies, Inc.

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice; acceptance for docketing.

-----------------------------------------------------------------------

SUMMARY: The NRC staff has determined that the partial application for 
a construction permit, submitted by SHINE Medical Technologies, Inc., 
is acceptable for docketing.

ADDRESSES: Please refer to Docket ID NRC-2013-0053 when contacting the 
NRC about the availability of information regarding this document. You 
may access information related to this document, which the NRC 
possesses and is publicly available, using any of the following 
methods:
     Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2013-0053. Address 
questions about NRC dockets to Carol Gallagher; telephone: 301-492-
3668; email: Carol.Gallagher@nrc.gov. For technical questions, contact 
the individual(s) listed in the FOR FURTHER INFORMATION CONTACT section 
of this document.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may access publicly available documents online in the NRC 
Library at http://www.nrc.gov/reading-rm/adams.html. To begin the 
search, select ``ADAMS Public Documents'' and then select ``Begin Web-
based ADAMS Search.'' For problems with ADAMS, please contact the NRC's 
Public Document Room (PDR) reference staff at 1-800-397-4209, 301-415-
4737, or by email to pdr.resource@nrc.gov. The application is available 
in ADAMS under accession number ML130880226.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.

FOR FURTHER INFORMATION CONTACT: Steven Lynch, Project Manager, Office 
of Nuclear Reactor Regulation, U.S. Nuclear Regulatory Commission, 
Washington, DC, 20555-0001; telephone: 301-415-1524; email: 
Steven.Lynch@nrc.gov.

SUPPLEMENTARY INFORMATION: On March 26, 2013, SHINE Medical 
Technologies (SHINE) filed with the U.S. Nuclear Regulatory Commission 
(NRC), pursuant to Section 103 of the Atomic Energy Act and part 50 of 
Title 10 of the Code of Federal Regulations (10 CFR), a portion of an 
application for a construction permit for a medical radioisotope 
production facility in Janesville, Wisconsin (SMT-2013-012, NRC's ADAMS 
Accession No. ML13088A192). A notice of receipt and availability of 
this application was previously published in the Federal Register (78 
FR 29390) on May 20, 2013.
    An exemption from certain requirements of 10 CFR 2.101(a)(5) 
granted by the Commission on March 20, 2013 (ADAMS Accession No. 
ML13072B195), in response to a letter from SHINE dated February 18, 
2013 (ADAMS Accession No. ML13051A007), allowed for SHINE to submit its 
construction permit application in two parts. Specifically, the 
exemption allowed SHINE to submit a portion of its application for a 
construction permit up to six months prior to the remainder of the 
application regardless of whether or not an environmental impact 
statement or a supplement to an environmental impact statement is 
prepared during the review of its application. The first part of 
SHINE's construction permit application consisted of the following 
information:
     The description and safety assessment of the site required 
by 10 CFR 50.34(a)(1)
     The environmental report required by 10 CFR 50.30(f)
     The filing fee information required by 10 CFR 50.30(e) and 
10 CFR 170.21
     The general information required by 10 CFR 50.33
     The agreement limiting access to classified information 
required by 10 CFR 50.37
    The NRC staff has determined that SHINE has submitted the 
information listed above in accordance with 10 CFR 2.101(a)(5), and 
that the partial application is acceptable for docketing. The docket 
number established for SHINE is 50-608.
    The NRC staff will perform a detailed technical review of the 
partial construction permit application. Docketing of the partial 
construction permit application does not preclude the NRC from 
requesting additional information from the applicant as the review 
proceeds, nor does it predict whether the Commission will grant or deny 
the application. The NRC staff will also perform an acceptance review 
of the second and final part of the construction permit application 
when it is tendered. As stated in SHINE's March 26, 2013, letter, the 
second and final part of SHINE's application for a construction permit 
will contain the remainder of the preliminary safety analysis report 
required by 10 CFR 50.34(a) and will be submitted in accordance with 
the requirements of 10 CFR 2.101(a)(5). If, after completion of the 
acceptance review of the full construction permit application, the full 
construction permit application is found acceptable for docketing, the 
Commission will conduct a hearing in accordance with Subpart L, 
``Informal Hearing Procedures for NRC Adjudications,'' of 10 CFR Part 2 
and will receive a report on the construction permit application from 
the Advisory Committee on Reactor Safeguards consistent with 10 CFR 
50.58, ``Hearings and report of the Advisory Committee on Reactor 
Safeguards.'' The Commission will announce in a future Federal Register 
notice, the opportunity to petition for leave to intervene in the 
hearing required for this application by 10 CFR 50.58, as well as the 
time and

[[Page 39343]]

place of the hearing. If the Commission finds that the full 
construction permit application meets the applicable standards of the 
Atomic Energy Act and the Commission's regulations, and that required 
notifications to other agencies and bodies have been made, the 
Commission will issue a construction permit, in the form and containing 
conditions and limitations that the Commission finds appropriate and 
necessary.
    In accordance with 10 CFR part 51, the Commission will also prepare 
an environmental impact statement for the proposed action. Pursuant to 
10 CFR 51.26, and as part of the environmental scoping process, the NRC 
staff intends to hold a public scoping meeting. Detailed information 
regarding this meeting will be included in a future Federal Register 
notice.

    Dated at Rockville, Maryland, this 25th day of June, 2013.
For the Nuclear Regulatory Commission.
Alexander Adams, Jr.,
Chief, Research and Test Reactors Licensing Branch, Division of Policy 
and Rulemaking, Office of Nuclear Reactor Regulation.
[FR Doc. 2013-15678 Filed 6-28-13; 8:45 am]
BILLING CODE 7590-01-P